Login / Signup

Effects of PEG-Linker Chain Length of Folate-Linked Liposomal Formulations on Targeting Ability and Antitumor Activity of Encapsulated Drug.

Chaemin LimYuseon ShinKioh KangPatihul HusniDayoon LeeSehwa LeeHan-Gon ChoiEun Seong LeeYu Seok YounKyung Taek Oh
Published in: International journal of nanomedicine (2023)
Our study suggests that as the length of PEG-linker increases, the tumor-targeting ability can be enhanced under in vivo conditions, which can lead to an increase in the antitumor activity of the encapsulated drug.
Keyphrases
  • drug delivery
  • cancer therapy
  • adverse drug
  • emergency department
  • electronic health record